Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms.

Journal of pediatric gastroenterology and nutrition - 1 May 2013

Sherlock Mary E, Walters Thomas, Tabbers Merit M, Frost Karen, Zachos Mary, Muise Aleixo, Pope Elena, Griffiths Anne M

Abstract excerpt

BACKGROUND: Infliximab (IFX), an established therapy for pediatric Crohn disease (CD), is also efficacious in treating psoriasis, a skin disorder, in which tumor necrosis factor-α is implicated pathogenically. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Infliximab

Share to Psoriasis

Share to Receptors, Interleukin

Share to Steroids

Source

Identifiers

PMID: 23274341
DOI: 10.1097/MPG.0b013e31828390ba

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23274341-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms.PMID 23274341Read ↗

Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease.Semantic proximity Read ↗

Evaluation of the interleukin-23 receptor gene coding variant R381Q in pediatric and adult Crohn disease.Semantic proximity Read ↗

Risk of Inflammatory Bowel Disease in Psoriasis Patients Treated with Anti-Interleukin-17 Agents: A Bayesian MetaanalysisSemantic proximity Read ↗

Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children.Semantic proximity Read ↗

Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.Semantic proximity Read ↗

IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.Semantic proximity Read ↗

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.Semantic proximity Read ↗

Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study.Semantic proximity Read ↗

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.Semantic proximity Read ↗

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.Semantic proximity Read ↗

Ustekinumab in Pediatric Crohn Disease Patients.Semantic proximity Read ↗

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.